Nice-Pak, a leading producer of private label wipes including varieties for surface disinfection applications, is working with Microbac, a testing laboratory, to determine if its products are effective specifically against SARS-CoV-2. Its sister company, PDI, which concentrates on the commercial and institutional sectors, is also submitting products to these tests.
Nice-Pak, which already has a number of products listed on the EPA’s list of disinfectants to use against SARS-CoV-2, will be among the first to get this certification.
This is an important angle, as Nielsen notes that the ability protect against germs and bacteria is a high priority for consumers. Consumers throughout the world are willing to pay more for homecare products that keep the family protected against germs/bacteria or that kill germs/bacteria in an effective way. Products that give consumers greater confidence will have a leg up on the competition.
For more information, see The Freedonia Group’s coverage of the Wipes and Global Nonwovens industries.